Orpyx®

Orpyx® is a Calgary-based medical technology company founded in 2010. It specializes in wearable digital health therapeutics aimed at preventing and managing diabetic foot complications. The company focuses on improving the quality of life for individuals with diabetes by addressing the risks associated with diabetic foot ulcers and amputations through advanced sensor-based technology. The flagship products, SurroSense Rx™ and SurroGait Rx™, are the first diabetic insole sensory substitution systems. These custom-made insoles feature sensors that monitor plantar pressure, temperature, step count, and hours worn. They provide real-time audiovisual alerts to users, helping them take immediate action to prevent tissue damage. The data collected is accessible to healthcare providers via a cloud-based dashboard, facilitating proactive treatment planning. Orpyx targets diabetic patients at risk of foot ulcers and healthcare providers managing diabetic limb care. The company aims to reduce the incidence of ulcers and amputations, ultimately improving patient outcomes and lowering healthcare costs. Led by Dr. Breanne Everett, Orpyx is committed to patient-centered innovation and has secured significant funding to advance its technology.

• Employees 71
• Founded 2010
• Annual Revenue $9500000
• Total Funding $30078054